Literature DB >> 20990952

Synthetic antimalarials; the preparation of certain 4-aminoquinolines.

N L DRAKE, H J CREECH.   

Abstract

Entities:  

Keywords:  MALARIA/therapy; QUINOLINES

Mesh：

Substances：

Year:  1946        PMID： 20990952     DOI： 10.1021/ja01211a021

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  4 in total

1.  Sontochin as a guide to the development of drugs against chloroquine-resistant malaria.

Authors:  Sovitj Pou; Rolf W Winter; Aaron Nilsen; Jane Xu Kelly; Yuexin Li; J Stone Doggett; Erin W Riscoe; Keith W Wegmann; David J Hinrichs; Michael K Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines.

Authors:  Kimberly Yearick; Kekeli Ekoue-Kovi; Daniel P Iwaniuk; Jayakumar K Natarajan; John Alumasa; Angel C de Dios; Paul D Roepe; Christian Wolf
Journal:  J Med Chem       Date:  2008-03-18       Impact factor: 7.446

3.  4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria.

Authors:  Jayakumar K Natarajan; John N Alumasa; Kimberly Yearick; Kekeli A Ekoue-Kovi; Leah B Casabianca; Angel C de Dios; Christian Wolf; Paul D Roepe
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

Review 4.  Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.

Authors:  Sultan A M Saghir; Naif A AlGabri; Mahmoud M Alagawany; Youssef A Attia; Salem R Alyileili; Shaaban S Elnesr; Manal E Shafi; Omar Y A Al-Shargi; Nader Al-Balagi; Abdullah S Alwajeeh; Omar S A Alsalahi; Amlan K Patra; Asmaa F Khafaga; Ahmed Negida; Ahmed Noreldin; Wesam Al-Amarat; Amer A Almaiman; Khaled A El-Tarabily; Mohamed E Abd El-Hack
Journal:  Ther Clin Risk Manag       Date:  2021-04-28       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.